Literature DB >> 22057972

High level of miR-21, miR-10b, and miR-31 expression in bilateral vs. unilateral breast carcinomas.

Aglaya G Iyevleva1, Ekatherina Sh Kuligina, Nathalia V Mitiushkina, Alexandr V Togo, Yoshio Miki, Evgeny N Imyanitov.   

Abstract

We analyzed the expression of several microRNAs (miRs) implicated in breast cancer (BC) pathogenesis (miR-21, miR-10b, miR17-5p, mir-31, miR-155, miR-200c, miR-18a, miR-205, and miR-27a) in 80 breast carcinomas obtained from patients with bilateral BC (biBC) and 40 cases of unilateral BC (uBC). Unexpectedly, three miRs (miR-21, miR-10b and miR-31) demonstrated significantly higher level of expression in biBC vs. uBC (P = 0.0001, 0.00004 and 0.0002, respectively). Increased contents of miR-21, miR-10b and miR-31 were observed in all categories of biBC tumors, i.e., in synchronous biBC as well as in first and second tumors from metachronous biBC cases. Synchronous biBC showed more similarity of miR expression profiles within pairs that the metachronous doublets (P = 0.004). This study suggests that bilateral breast tumors have somewhat distinct pattern of molecular events as compared to the unilateral disease.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22057972     DOI: 10.1007/s10549-011-1845-z

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  13 in total

1.  Many Roles of CCL20: Emphasis on Breast Cancer.

Authors:  Kingsley O Osuala; Bonnie F Sloane
Journal:  Postdoc J       Date:  2014-03

Review 2.  MicroRNA in intervertebral disc degeneration.

Authors:  Zheng Li; Xin Yu; Jianxiong Shen; Matthew T V Chan; William Ka Kei Wu
Journal:  Cell Prolif       Date:  2015-03-04       Impact factor: 6.831

3.  In Vivo Detection of miRNA Expression in Tumors Using an Activatable Nanosensor.

Authors:  Byunghee Yoo; Amol Kavishwar; Alana Ross; Pamela Pantazopoulos; Anna Moore; Zdravka Medarova
Journal:  Mol Imaging Biol       Date:  2016-02       Impact factor: 3.488

4.  Silicon nanowires with high-k hafnium oxide dielectrics for sensitive detection of small nucleic acid oligomers.

Authors:  Brian R Dorvel; Bobby Reddy; Jonghyun Go; Carlos Duarte Guevara; Eric Salm; Muhammad Ashraful Alam; Rashid Bashir
Journal:  ACS Nano       Date:  2012-06-22       Impact factor: 15.881

5.  Interaction of the oncogenic miR-21 microRNA and the p53 tumor suppressor pathway.

Authors:  Xiaodong Ma; Saibyasachi N Choudhury; Xiang Hua; Zhongping Dai; Yong Li
Journal:  Carcinogenesis       Date:  2013-02-05       Impact factor: 4.944

6.  Polymer nanoparticles mediated codelivery of antimiR-10b and antimiR-21 for achieving triple negative breast cancer therapy.

Authors:  Rammohan Devulapally; Narayana M Sekar; Thillai V Sekar; Kira Foygel; Tarik F Massoud; Jürgen K Willmann; Ramasamy Paulmurugan
Journal:  ACS Nano       Date:  2015-02-23       Impact factor: 15.881

7.  MicroRNA 10b promotes abnormal expression of the proto-oncogene c-Jun in metastatic breast cancer cells.

Authors:  Revital Knirsh; Iris Ben-Dror; Shira Modai; Noam Shomron; Lily Vardimon
Journal:  Oncotarget       Date:  2016-09-13

8.  Prognostic and Clinicopathological Significance of MiR-155 in Breast Cancer: A Systematic Review.

Authors:  Anna Maria Grimaldi; Silvia Nuzzo; Gerolama Condorelli; Marco Salvatore; Mariarosaria Incoronato
Journal:  Int J Mol Sci       Date:  2020-08-14       Impact factor: 5.923

9.  MiR-27 as a prognostic marker for breast cancer progression and patient survival.

Authors:  Wei Tang; Jiujun Zhu; Shicheng Su; Wei Wu; Qiang Liu; Fengxi Su; Fengyan Yu
Journal:  PLoS One       Date:  2012-12-11       Impact factor: 3.240

10.  MicroRNA-regulated protein-protein interaction networks and their functions in breast cancer.

Authors:  Chia-Hsien Lee; Wen-Hong Kuo; Chen-Ching Lin; Yen-Jen Oyang; Hsuan-Cheng Huang; Hsueh-Fen Juan
Journal:  Int J Mol Sci       Date:  2013-05-30       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.